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ABSTRACT
Recent studies indicate an important role for vitamin D3 in autism spectrum disorder (ASD),
although its mechanism is not completely understood. The most puzzling aspect of ASD is that
identical twins, who share identical DNA, do not have 100% concordance rates (»88% for identical
and »31% for fraternal twins). These ﬁndings provide major clues into the etiology: ASD must
involve an environmental factor present in the prenatal milieu that both identical twins are not
always exposed to because they do not always share it (i.e., placentas). Combined with the
exponential increasing rates of ASD around the world, these observations suggest a contagious
disease is probably transferred to the fetus via the placenta becoming infected by a cervical virus.
Vitamin D3 boosts immune responses clearing viral infections and increases serotonin and estrogen
brain levels. Here we review the different roles and untangle the most probable one vitamin D3
plays in ASD.
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The most puzzling aspect of autism spectrum disor-
der (ASD) is that identical twins, who share identi-
cal DNA, do not have 100% concordance rates.
Identical, monozygotic twins only have concordance
rates of »88%, while fraternal, dizygotic twins have
concordance rates of »31%.1,2 These twin observa-
tions alone provide clues into the etiology: ASD
must involve something present in the prenatal
environment that both identical twins are not
always exposed to because they do not always share
it. Identical twins can share the same placenta and
amniotic sac (occurrence »1%) or they can share
the same placenta but not their amniotic sac (occur-
rence »69%) or they can have their own placentas
and amniotic sacs (occurrence »30%), while frater-
nal twins always have their own placentas and
amniotic sacs3 (see Fig. 1). The subtle differences
between the prenatal environments of identical
twins, especially their placentas, might explain why
a 100% concordance rate of ASD does not exist for
them. Thus, we need to closely examine the prenatal
environment of twins.
Prenatal soluble factors
Many soluble factors exist in the prenatal environment
that can possibly affect the developing fetus: vitamins,
hormones, cytokines, chemicals, alcohol, drugs, medi-
cations, etc. A prenatal environment with low levels of
vitamin D3, measured as 25-hydroxyvitamin D3, was
hypothesized to cause ASD.4 Recent investigations con-
ﬁrm low maternal 25-hydroxyvitamin D3 levels during
gestation are associated with ASD-related traits in a
large population-based sample5 and supplementing
children with vitamin D3 improve the signs and symp-
toms of ASD.6 However, although vitamin D3 treat-
ment is beneﬁcial for improving and possibly
preventing some of the symptoms of ASD or even low-
ering its occurrence, those observations do not prove a
causal relationship exists because low 25-hydroxyvita-
min D3 levels are shared between twins in their prena-
tal environment whether they are identical or not. In
fact, any circulating soluble factor like cytokines, medi-
cations, alcohol, drugs, or exposure to any chemical in
our environment would give a 100% concordance rate
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for either identical or fraternal twins, but this is not
observed. Thus, something else must be awry that vita-
min D3 somehow differentially affects.
Vitamin D3 – estrogen, serotonin and immune
function
The hormonal form of vitamin D3, 1, 25-dihydroxyvita-
min D3, affects over 200 genes through the vitamin D3
receptor,7 but more importantly it increases estrogen lev-
els in the placenta8 and the brain9 and is probably neces-
sary for regulating serotonin production.10 Estrogen
brain levels might help to somewhat explain why males
are 4 to 5 times more likely to become autistic than
females11 because estrogen is extremely important in
brain development.12 Of note, ASD subjects displayed
dysregulation of the estrogen receptor beta, aromatase,
and estrogen receptor co-activators in the middle frontal
gyrus region of their brains.13 Racial disparity supports a
causal role for estrogen rather than vitamin D3 in ASD
because African-American blacks have lower vitamin D3
status than whites14 but instead of having higher inciden-
ces of ASD their incidences are actually lower15–17 proba-
bly because their male’s estrogen levels are signiﬁcantly
higher than white males.18 Estrogen increases the synthe-
sis of tryptophan hydroxylase-2, the rate-limiting enzyme
in the production of serotonin,19 and vitamin D3 also
increases tryptophan hydroxylase-2.10 Apparently some
of the positive effects of vitamin D3, or 1, 25-
dihydroxyvitamin D3, on ASD is its ability to raise both
estrogen and serotonin levels during fetal brain
development.20
Another important biological function of vitamin
D3 is its ability to activate the mother’s immune sys-
tem,21 especially T cells22 that remove infected cells
and infectious agents like bacteria and viruses in the
mother, especially from her cervix. Thus, if ASD is
caused by an infectious agent, boosting the immune
system with vitamin D3 might also help to explain its
positive effects.
Infectious placental and cervical diseases
The increase in the incidence of ASD is much faster
than that predicted from genetic inheritance or from
exposure to environmental pollutants23 but rather dis-
plays characteristics of an infectious disease because it
is increasing at an exponential rate in the United
States (see Fig. 2, plotted from the data in reference
24) and around the world.24 This infectious disease is
probably either a bacterium or a virus.25 We can rule
out bacterial infections because they would have been
noticed on hematoxylin and eosin stained slides of dif-
ferent tissues and would have produced other health
problems. So, if it is an infection, it is most likely a
viral infection.26 Human immunodeﬁciency virus was
a candidate over two decades ago that did not pan
out27 but co-infections are common so that other
viruses should be considered. Evidently, the virus that
may cause ASD does not cause any obvious symptoms
or it would have been discovered years ago.
Figure 1. Identical and fraternal twin placenta and amniotic sac
possibilities and percent occurrences: shared placentas (mono-
chorionic), separate placentas (dichorionic), shared amniotic sacs
(monoamniotic) and separate amniotic sacs (diamniotic). The pla-
centa is represented by an oval with a large dark disc in the
middle.
Figure 2. Incidence ASD/1,000 children over time in the United
States. Plotted from the data in reference 24. Note that an expo-
nential increase over time for ASD occurs around the world pri-
marily in developed countries.
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Which viral infection?
We know viral infections can affect the developing
fetal brain from the Zika virus that causes microence-
phaly. Evidence that ASD might be caused by a virus
is obtained from affected children’s increased levels of
the virally-induced enzyme, alpha-N- acetylgalactosa-
minidase,28 similar to women with cervical cancer
whose enzyme levels are elevated by the Human Papil-
lomavirus (HPV).29
HPV is vertically transmitted from the mother’s
infected cervix to her placenta and then to her fetus
rather than through her blood.30,31 Further proof of
placental transmission of HPV rather than blood is
obtained from the prevalence of HPV DNA, which
was found to be considerably lower in newborns
(»1.5% or »1/68) of infected mother’s (»30% popu-
lation of pregnant women).32 Coincidentally, this
infection rate matches the incidence of 1 in 68 chil-
dren with ASD eight years later. HPV is known to
infect the trophoblasts of the placenta33 where inclu-
sions in it have been found to be predictive of ASD.34
Moreover, the discordant rates of identical twins
might be explained by the initial location of one of
their placentas being juxtapose to the cervix, where
HPV infection occurs; a low-lying placenta, which is a
fairly common occurrence, moves back up 90% of the
time during the second trimester35 and can sometimes
take HPV with it. Fraternal twins with only a 31%
concordant rate of ASD might be explained by one
twin having its placenta in closer proximity to the cer-
vix than the other twin whether or not it moves back
up (placenta previa if it remains low). And besides the
differences in estrogen levels, the higher male to
female ratio of ASD might be explained by the male
fetuses’ tendency to implant their placentas lower in
the uterus during the ﬁrst trimester, as demonstrated
by male fetuses having a higher incidence of placenta
previa (the reason is unknown).36,37 Twins also have a
higher rate of placenta previa than singletons38 and
they have a higher rate of ASD as well.39,40 Further-
more, cesarean births increase the risk for placenta
previa41 and they also increase the risk for ASD.42
Finally, the increase in ASD with increasing age of the
mother might be explained by the increasing inci-
dence of placenta previa as women age.43 Thus, timing
of HPV infection during pregnancy might be impor-
tant because HPV probably has to be replicating in
the cervix during the ﬁrst trimester while the placenta
is low-lying in the uterus prior to moving back up;44,45
however, if placenta previa occurs or if the infection
travels higher into the uterus, then transfer of the
infection can occur at any time during pregnancy.
Supporting evidence HPV is the primary
infecting agent
Some argue that HPV cannot exist in the brain
because it only infects mucosal (alpha genus) or epi-
thelial (beta and gamma genera) cells and those cell
types are not present inside the brain. It is true that no
mucosal or epithelial cells exist inside the brain, but
there is an epithelial lining in the center of the brain
known as the choroid plexus that forms the blood-
cerebrospinal ﬂuid barrier and is responsible for pro-
ducing cerebrospinal ﬂuids.46 Although the choroid
plexus appears to be a small structure, it affects every
region of the brain during early embryogenesis and
throughout brain development through the produc-
tion of cerebral ﬂuids;47 we now know that every
region of the ASD brain is affected to some degree
and that there is serious disruption in the central ner-
vous system.48 The epithelial cells of the choroid
plexus secrete cerebrospinal ﬂuid by unidirectionally
transporting sodium, chlorine and bicarbonate from
the blood to the ventricles of the brain. The sodium-
driven chloride bicarbonate exchanger, or SCL4A10
gene product,49 is associated with ASD50 and HPV
integration into the host genome might lead to dupli-
cation of this gene. Disruption in this one gene aug-
ments neuronal excitability and synaptic short-term
plasticity51 and might cause complex partial epilepsy
and mental retardation.52 Although controversial,
some studies found HPV in the post-mortem brains
of children with focal cortical dysplasia (epilepsy and
seizures),53 a condition also associated with ASD.54
Curiously, papillomas have been found in the cho-
roid plexus of adults and children55,56 and tumors
have been found in the choroid plexus in children
under the age of 2.57 Another curious observation is
the fact that about 75% of ASD children have gastroin-
testinal problems including inﬂammatory bowel dis-
ease58 and a single layer of epithelium cells very
similar to the choroid plexus with similar functions
and immune responses exist in the gastrointestinal
tract;59 vitamin D3 reduces the symptoms. Further-
more, inﬂammation of the brain is a hallmark of ASD
and inﬂammatory cytokines are in the cerebrospinal
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ﬂuids of affected children.60 Microglia cells are the ﬁrst
line of defense to rid the brain of infections resulting
in an inﬂammatory response61 and differential M2
activation of microglia cells in ASD brains is driven by
type 1 interferon responses to damage caused by viral
infections.62 This inﬂammatory response continues
throughout the lifetime of an ASD individual, proba-
bly caused by HPV continually producing virions, and
this inﬂammation might be reduced by vitamin D3.63
Recently, the MRIs of children’s brains at 6 or
12 months of age that showed abnormal amounts of
cerebrospinal ﬂuid displayed ASD traits at 2 yrs. of
age; the more cerebrospinal ﬂuid present, the worse
the ASD symptoms were later in life.64
Similarities between Cancer and ASD?
If HPV is involved in ASD, we would expect to see
many biochemical similarities between cancer and
ASD – and we do!65 Most importantly, both cancer
and ASD share disruptions in the PI3K-Akt-mTOR
signaling pathway involving PTEN, FMR1, NF1,
TSC1 and TSC2, and both share signal transduction
pathways, chromatin remodeling and transcription
factors. What is most amazing and speciﬁc for HPV in
cancer is its E6 activation of mTORC1 signaling66
and, coincidently, mTORC1 and PTEN are also asso-
ciated with ASD.67 The mTOR protein is a serine/
threonine kinase involved in brain development medi-
ating signaling pathways crucial for neuronal and glial
differentiation and maintenance of the stemness of
neural stem cells; abnormalities in its function are
associated with ASD, seizures, pediatric brain tumors,
learning disabilities, and mental retardation.68
Another shared gene between ASD and HPV-induced
cancers is UBE3A, which encodes the ubiquitin E3
ligase, E6-AP that degrades p53 and other pro-
teins.69,70 If HPV is involved in ASD, we would expect
to see a higher incidence of cancers in this population
– and we do!71,72
Note here that HPV-16 or ¡18 might not be the
strains that cause ASD; it could be HPV-11 or HPV-
58, or one or more, or possibly all of the other 200C
available strains.73 Alternatively, it might be another
sexually transmitted infection of the cervix.74 Other
viruses and infections such as inﬂuenza, rubella, cyto-
megalovirus, parvovirus, Lyme’s disease or toxo-
plasma gondii infection have sometimes been
implicated in ASD. However, no correlation between
any viral, bacterial, or parasitic infections could con-
sistently be reliably made with ASD and appeared to
be coincidental occurrences; whereas, HPV infection
has never been explored probably because it is thought
to only cause cancers. And the fact that HPV has been
found in adult brain tumors such as glioblastoma
multiforme75 without any ASD symptoms can be
explained by the mode of transmission; the adult
becomes infected with HPV via sexual transmission
after their brain has developed rather than the fetus
that becomes infected with HPV via placentas while
their brain is developing. Finally, HPV has also been
found in neurons.76 Thus, although other infections
may sometimes be associated with ASD, HPV appears
to be the primary infectious agent.
Do HPV’s biochemical and epigenetic
ﬁngerprints match ASD’s ﬁngerprints?
We can obtain evidence that HPV is a risk factor for
ASD by looking at its incidence rate, and characteristic
biochemical and epigenetic ﬁngerprints. Unlike other
sexually contagious diseases, the incidence of HPV
infection has been exponentially increasing in the
United States (Fig. 3)77 like ASD (Fig. 2).24 Meanwhile,
vitamin D3 status has been dramatically decreasing
over the last ﬁve decades, as shown by the inversely-
related parathyroid hormone levels that have
decreased nearly ten-fold during the same period.78
Vitamin D3 is important for proper immune func-
tion,79 especially enabling activated T cells to eliminate
virally infected cells22 and to clear viral infections.80
Vitamin D3 also decreases leptin levels81 that were
Figure 3. Incidence HPVC oropharyngeal cancers/100,000 world
population over time in the United States. Plotted from the data
in reference 77.
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found to be higher in ASD children82 and older
women who have a persistent HPV infection.83 HPV
causes preeclampsia, or high blood pressure, in preg-
nant women84 and so does ASD.85 Furthermore, ASD
children’s brains have downregulated estrogen recep-
tor beta in their middle frontal gyrus region13 where
sexual dimorphisms have been observed86 and HPV
can downregulate estrogen receptor beta,87 which in
turn can downregulate the vitamin D3 receptor.
88 And
among the multitudes of HPV’s genomic integration
sites, one happens to be at 12q13-1589 where the vita-
min D3 receptor gene is located;
90 integration might
decrease or annihilate its function. The fact that
African-American blacks have lower vitamin D3 sta-
tus14 while they have a higher prevalence of HPV91
but lower incidences of ASD15–17 might be explained
by their males having signiﬁcantly higher estrogen lev-
els than white males.18
Genetic or epigenetic component?
For the most part, ASD cannot be inherited or caused
by sporadic genetic mutations because it is increasing
at an exponential rate indicting it has a contagious epi-
demic aspect (Fig. 2); the belief that ASD’s exponential
increase is due to over diagnosis was laid to rest more
than a decade ago by the CHARGE study.92 Argu-
ments that epigenetics plays a major role in ASD have
been escalating over recent years93 – with little evi-
dence that ASD might begin with a sexually transmit-
ted disease – except noted in the very religious and
somewhat isolated Amish community by having a low
ASD rate of 1 in 271 children compared with the over-
all United States having a high ASD rate of 1 in 91
children in 2009.94 Because identical twins were 88%
and fraternal twins were only 31% concordant for
ASD along with an increased rate (10–20 times
higher) over the general population’s recurrence in
siblings,1 investigators thought ASD was a ‘highly’
inheritable, genetic disease. As a result, over 800 dif-
ferent predisposition genes have been identiﬁed so far
with little consensus; these genes are involved in a
multitude of different functions: chromatin remodel-
ing, gene transcription regulation, cell growth and
proliferation, ubiquitination, and neuronal-speciﬁc
processes like synaptic activity and organization, den-
dritic morphology, and axonogenesis.95 In addition,
copy number variants have been implicated in ASD50
but once again like the different infections noted in
some cases of ASD, they were not found to be univer-
sal.96 Logic dictates that for identical twins to be
»12% discordant in ASD very few genes can be
involved in its etiology due to the rare frequency of
functional mutations. Some consensus has been
reached on a few genetic loci that appear to be recur-
rently duplicated or deleted such as chromosomal
regions 15q11-q13, 16p11 and 22q11; note that region
15q11-q13 encodes for UBE3A, the ubiquitin E3
ligase, E6-AP that degrades p53 and other proteins
and is duplicated in ASD97 possibly from viral
intervention.
The fact that few genes are consistently changed but
many genes appear to be involved might be explained
by epigenetic events inﬂuencing multitudes of genetic
pathways, which can make ASD appear to be genetic
when it is not.98 DNA methylation patterns, long non-
coding RNAs and microRNAs99,100 combined with
the persistence of HPV infection might make ASD
appear to be genetic because so many genes are
affected. In addition, some mothers are not able to
clear the virus before having another child, so that
reoccurrence in siblings also makes ASD appear to be
genetic. Over half the women were still infected with
HPV after 2 years,101 which might explain why the
spacing between pregnancies of 1 year is 3 times risk-
ier for having a second baby with ASD than 3 years.2
Moreover, DNA methylation is signiﬁcantly different
between identical twins discordant for ASD,102 and is
aberrant in cervical103 and only in HPVC not HPV-
oropharyngeal cancers.104 Another deceiving genetic
connection is HPV integrating into the host genome
at multiple sites (>190), mapped from cervical can-
cers,105–107 but note that the integration sites in ASD
might differ somewhat from cervical cancer or could
be caused by another strain of HPV other than 16 or
18. Integration can result in deletion or duplication of
a section of the DNA and considerable genomic insta-
bility108 similar to what is observed in ASD.109 Besides
epigenetic events leading to aberrant gene expression
in ASD, some of the point mutations observed might
be due to methylation of cytosines leading to deami-
nation that result in transition mutations.110 Finally,
because HPV is sometimes found in sperm111 but is
usually transmitted vertically from the mother’s pla-
centa,112 ASD can appear to be genetically transferred
when it is not.
Epigenetic ﬁngerprints of ASD and HPV might
appear to be smudged sometimes because ASD and
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cancer researchers each concentrate on searching for
endpoints related to their particular disease, so that
they miss the relevant endpoints in each other’s dis-
eases; when they both might be looking at opposite
sides of the same coin.
HPV strains found in cervical smears
The highest occurring strains of HPV in the uterine
cervix associated with developing cervical carcinomas
and precancerous lesions from the highest to lowest
occurrence are HPV-16, ¡58, ¡18, ¡52, and ¡56 fol-
lowed by the low risk strains.113 This was determined
by a PCR-based DNA chip microarray detection
method of cervical smears that can assess 22 different
strains of HPV including 15 from the high-risk group,
HPV-16, ¡18, ¡31, ¡33, ¡35, ¡39, ¡45, ¡51, ¡52,
¡56, ¡58, ¡59, ¡66, ¡68, ¡69 and 7 from the low-
risk group, HPV-6, ¡11, ¡34, ¡40, ¡42, ¡43,
¡44.113 It is important to note once again that these
strains of HPV are the high- and low-risk groups for
cervical cancers and that they might not reﬂect the
same risk for ASD. In addition, multiple strains of
HPV might be required to produce ASD. Because
Papanicolaou (Pap) smears only detect cancerous cells
– not the presence of HPV114 – this PCR method or
another HPV detection method should be used in
combination with a second, different HPV detection
method for conﬁrmation115,116 during routine cervical
exams. Be aware that other PCR-based methods some-
times detected HPV when this PCR-based microarray
chip method did not, which is probably due to differ-
ences in their sensitivities.
This difference in sensitivities between detection
methods points out how important it is to use multiple
detection methods and approaches to ﬁnd and con-
ﬁrm the existence of HPV, and to use broad spectrum
probes before searching for speciﬁc strains. Further-
more, ampliﬁcation of the signal is best because HPV
might be missed due to a weak signal.117 Alternatively,
HPV might be missed due to the timing of infection
or when some observations are performed, which
might be critical because HPV can cause opposite bio-
logical effects during different phases of its life cycle.
For example, in the beginning, HPV uses estrogen and
its receptors to make more E6 and E7 proteins, but
towards the end of its life cycle, in differentiated cells
(and possibly third trimester fetuses), it downregulates
estrogen and its receptors118 and increases p16 when
it makes capsid proteins L1 and L2. Thus, it is best to
cover both ends of HPV’s life cycle.
Treatment and prevention options
If HPV is found guilty for being the contributing factor in
ASD, the future incidence and current symptoms might
be reduced by increasing both the mother’s and child’s
25-hydroxyvitamin D3 levels to at least 50 ng/mL using
adequate amounts of vitamin D3119, 120, 121 to raise estro-
gen and serotonin levels, decrease leptin levels and
inﬂammation, and improve brain function122 of the
fetuses and children, while clearing existing HPV infec-
tions in the mother and children over 18 months of age.
In addition, increasing estrogen and tryptophan (for
serotonin synthesis) levels might help the brain to
develop better. And recently new treatments for ASD tar-
get inhibiting the mTOR pathway;123 Rapamycin shows
promise for treating ASD124 and coincidently it is also
being used to improve clearance during treatment of
HPV-positive head and neck cancers.125 More impor-
tantly, vaccinating mothers prior to and even during
pregnancy (found to be safe and provides passive immu-
nity to the neonate and infant)126 and giving at least two
doses of the nine-valent HPV vaccine to ASD children
(over 18 months old when they have a competent
immune system) might boost their immune systems to
clear HPV and help improve the symptoms in some
ASD cases, because the quadrivalent vaccine was found
to decrease or eliminate the occurrence of oral and genital
warts.127,128 However, these current HPV vaccines might
not completely protect against the strain(s) of HPV that
cause the entire spectrum of autism so that another or
other vaccines might have to be developed. For example,
along with HPV-16 and¡18, HPV-38 has been found in
melanomas and are implicated in its etiology.129–131 Most
importantly, note that the cervical Pap smears only detect
cancerous cells and not the presence of HPV, so that it
would be wise to include a broad-spectrum HPV test
along with routine Pap smears in the future, especially
for women who intend to get pregnant or who already
are pregnant.
Conclusions
The fact that identical twins, who share identical DNA,
do not have 100% concordance rates shows genetics plays
a minor role (excluding epigenetic events) and some
environmental factor that differs between twins plays a
major role in ASD. Because identical twins only share
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their placentas about 70% of the time and their concor-
dance rates are only »88%, an environmental factor
probably plays its role through the placenta. Low levels of
25-hydroxyvitamin D3, or any other soluble factor, can-
not be the cause of ASD because if it were, then all twins,
identical or not, would be affected but they are not. Thus,
the cause of ASD has to be something that vitamin D3
affects in the environment of the placenta. Based on
observations of placenta inclusions, predictive of ASD
and indicative of an infection, we proceeded to untangle
the major role vitamin D3 plays in ASD and found it is
probably to clear the viral infection that a low-lying pla-
centa picked up from the cervix. The most probable viral
infection is HPV because it is the only cervical infection
that is increasing at an exponential rate around the world
like ASD. HPV can exist in the epithelial lining in the
center of the brain known as the choroid plexus that
forms the blood-cerebrospinal ﬂuid barrier. The choroid
plexus secretes cerebrospinal ﬂuid by unidirectionally
transporting sodium, chlorine and bicarbonate from the
blood to the ventricles of the brain via the sodium-driven
chloride bicarbonate exchanger, or SCL4A10 gene prod-
uct, which is associated with ASD;50 HPV integration
into the host genome might lead to duplication of this
gene and elimination or disruption of the vitamin D3
receptor gene. More supporting evidence HPV is
involved in ASD is obtained from the epigenetic ﬁnger-
prints of HPV that match those of ASD, which also
makes it appear to be of genetic origin when it is not. The
roles of vitamin D3 in ASD include increasing the brain’s
estrogen and serotonin levels while decreasing inﬂamma-
tion via decreasing inﬂammatory cytokines produced by
activated microglia cells132 and reducing leptin levels.
The untangled major role for vitamin D3 in ASD and
most cancers133 is its ability to regulate 291 genes and
boost the immune system134 in order to clear HPV and
other viral infections.
Conﬂict of interest statement
The authors declare no conﬂict of interest.
Acknowledgments
We did not receive any ﬁnancial support for this research.
Author contributions
DEG planned the study, analyzed the data in the literature, and
was the primary author. SJM contributed to the scientiﬁc dis-
cussions and revising the ﬁnal version.
References
1. Rosenberg RE, Law JK, Yenokyan G, McGready J,
Kaufmann WE, Law PA. Characteristics and concor-
dance of autism spectrum disorders among 277 twin
pairs. Arch Pediatr Adolesc Med. 2009;163(10):907–914.
doi:10.1001/archpediatrics.2009.98.
2. Newschaffer CJ, Croen LA, Fallin MD, Hertz-Picciotto I,
Nguyen DV, Lee NL, Berry CA, Farzadegan H, Hess HN,
Landa RJ, et al. Infant siblings and the investigation of
autism risk factors. J Neurodev Disord. 2012;4(1):7.
doi:10.1186/1866-1955-4-7. PMID:22958474
3. Faye-Petersen OM, Heller DS, Joshi VV. Handbook of
Placental Pathology, 2nd ed. London: Taylor & Francis;
2006. ISBN 9781842142325
4. Cannell JJ. Autism and vitamin D. Med Hypotheses
2008;70(4):750–759. doi:10.1016/j.mehy.2007.08.016.
PMID:17920208
5. Vinkhuyzen AA, Eyles DW, Burne TH, Blanken
LME, Kruithof CJ, Verhulst F, Jaddoe VW, Tiemeier
H, McGrath JJ. Gestational vitamin D deﬁciency and
autism-related traits: the Generation R Study. Mol
Psychiatry. 2016. doi:10.1038/mp.2016.213. [Epub
ahead of print]. PMID:27895322
6. Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA,
El-Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina
MA, Abo-Elela MG, Ahmad FA, Abd El-Baseer KA,
Ahmed AE, Abdel-Salam AM Randomized controlled
trial of vitamin D supplementation in children with
autism spectrum disorder. J Child Psychol Psychiatry.
2016. doi:10.1111/jcpp.12652. [Epub ahead of print].
PMID:27868194
7. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ,
Lincoln MR, Burrellet A, Handunnetthi L, Handel AE,
Disanto G, Orton SM, Watson CT, Morahan JM, Gio-
vannoni G, Ponting CP, Ebers GC, Knight JC. A ChIP-
seq-deﬁned genome-wide map of vitamin D receptor
binding: Associations with disease and evolution.
Genome Research. 2010;20(10):1352–60. doi:10.1101/
gr.107920.110. [Epub 2010 Aug 24]. PMID:20736230
8. Barrera D, Avila E, Hernandez G, Mendez I, Gonzalez L,
Halhali A, et al. Estradiol and progesterone synthesis in
human placenta is stimulated by calcitriol. J Steroid Bio-
chem Mol Biol. 2007;103(3–5):529–522. doi:10.1016/j.
jsbmb.2006.12.097.
9. Yague JG, Garcia-Segura LM, Azcoitia I. Selective transcrip-
tional regulation of aromatase gene by vitaminD, dexameth-
asone, and mifepristone in human glioma cells. Endocrine.
2009;35(2):252–261. doi:10.1007/s12020-008-9134-2.
10. Kaneko I, Sabir MS, Dussik CM, Whitﬁeld GK, Karrys A,
Hsieh JC, Haussler MR, Meyer MB, Pike JW, Jurutka
PW. 1,25-Dihydroxyvitamin D regulates expression of
the tryptophan hydroxylase 2 and leptin genes: implica-
tion for behavioral inﬂuences of vitamin D. FASEB.
2015;29(9):4023–4035.doi:10.1096/fj.14-269811.
11. https://www.cdc.gov/ncbddd/autism/data.html accessed
on 01/02/2017
DERMATO-ENDOCRINOLOGY e1387702-7
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
12. McCarthy MM. Estradiol and the developing brain. Physiol
Rev. 2008;88(1):91–124. doi:10.1152/physrev.00010.2007.
13. Crider A, Thakkar R, Ahmed AO, Pillai A. Dysregulation
of estrogen receptor beta (ERb), aromatase (CYP19A1),
and ER co-activators in the middle frontal gyrus of
autism spectrum disorder subjects. Mol Autism.
2014;5:46. doi:10.1186/2040-2392-5-46. PMID:25221668
14. Ginde AA, Liu MC, Camargo CA Jr. Demographic differ-
ences and trends of vitamin D insufﬁciency in the US
population, 1988–2004. Arch Int Med. 2009;169:626–
632. doi:10.1001/archinternmed.2008.604.
15. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N,
Boyle C, Murphy C. Prevalence of autism in a US metro-
politan area. JAMA. 2003;289:49–55. doi:10.1001/
jama.289.1.49.
16. Bhasin TK, Schendel D. Sociodemographic risk factors
for autism in a US metropolitan area. J Autism Dev
Disord. 2007;37(4):667–77. doi:10.1007/s10803-006-
0194-y.
17. Christensen DL, Baio J, Braun KV, Bilder D, Charles J,
Constantino JN, Daniels J, Durkin MS, Fitzgerald RT,
Kurzius-Spencer M, et al. Prevalence and Characteristics
of Autism Spectrum Disorder Among Children Aged
8 Years — Autism and Developmental Disabilities Moni-
toring Network, 11 Sites, United States, 2012. MMWR
Surveill Summ. 2016;65(No. SS-3)(No. SS-3):1–23.
doi:10.15585/mmwr.ss6503a1
18. Rohrmann S, Nelson WG, Rifai N, Brown TR, Dobs A,
Kanarek JD, et al. Serum estrogen, but not testosterone,
levels differ between black and white men in a nationally
representative sample of Americans. J Clin Endocrinol
Metab. 2007;92:2519–2525. doi:10.1210/jc.2007-0028.
19. Hiroi R, Handa RJ. Estrogen receptor-b regulates human
tryptophan hydroxylase-2 through an estrogen response
element in the 50 untranslated region. J Neurochem.
2013;127(4):487–495. doi:10.1111/jnc.12401.
20. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin
interactions: implications for affective regulation. Biol
Psychiatry. 1998;44(9):839–850. doi:10.1016/S0006-3223
(98)00162-0.
21. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguar-
nera L. Vitamin D3: a helpful immuno-modulator.
Immunol. 2011;134(2):123–139. doi:10.1111/j.1365-
2567.2011.03482.x.
22. von Essen MR, Kongsbak M, Schjerling P, Olgaard K,
Odum N, Geisler C. Vitamin D controls T cell antigen
receptor signaling and activation of human T cells. Nat.
Immunol. 2010;11:344–349. doi:10.1038/ni.1851.
23. Nevison CD. A comparison of temporal trends in United
States autism prevalence to trends in suspected environ-
mental factors. Environ Health. 2014;13:73. doi:10.1186/
1476-069X-13-73. PMID:25189402
24. https://www.cdc.gov/ncbddd/autism/documents/asdpre
valencedatatable2016.pdf Accessed on 01/07/2017
25. Robbins JR, Bakardjiev AI. Pathogens and the placental
fortress. Curr Opin Microbiol. 2012;15:36–43.
doi:10.1016/j.mib.2011.11.006.
26. Atladottir HO, Thorsen P, Østergaard L, Schendel DE,
Lemcke S, Addallah M, Parner ET. Maternal infection
requiring hospitalization during pregnancy and autism
spectrum disorders. J Autism Dev Disord. 2010;40
(12):1423–1430. doi:10.1007/s10803-010-1006-y.
27. Musetti L, Albizzati A, Grioni A, Rossetti M, Saccani M,
Musetti C. Autistic disorder associated with congenital
HIV infection. European Child & Adolescent Psychiatry.
1993 2(4):221–225. doi:10.1007/BF02098581.
28. Bradstreet JJ, Vogelaar E, Thyer L. Initial observations of
elevated alpha-n- acetylgalactosaminidase activity associ-
ated with autism and observed reductions from GC pro-
tein—macrophage activating factor injections. Autism
Insights. 2012;4:31–38. doi:10.4137/AUI.S10485
29. Reddi AL, Sankaranarayanan K, Arulraj HS, Devaraj N,
Devaraj H. Serum alpha-N- acetylgalactosaminidase is
associated with diagnosis/prognosis of patients with
squamous cell carcinoma of the uterine cervix. Cancer
Lett. 2000;158(1):61–64. doi:10.1016/S0304-3835(00)
00502-4.
30. Rombaldi RL, Seraﬁni EP, Mandelli J, Zimmermann E,
Losquiavo KP. Transplacental transmission of human
papillomavirus. Virol J. 2008;5:106. doi:10.1186/1743-
422X-5-106. PMID:18817577
31. Weyn C, Thomas D, Jani J, Guizani M, Donner C, Van
Rysselberge M, Hans C, Bossens M, Englert Y, Fontaine
V. Evidence of human papillomavirus in the placenta.
2011;203(3):341–343. doi:10.1093/infdis/jiq056
32. Smith EM, Parker MA, Rubenstein LM, Haugen TH,
Hamsikova E, Turek LP. Evidence for vertical transmis-
sion of HPV from mothers to infants. Infect Dis Obstet
Gynecol. 2010a;2010:326369. doi:10.1155/2010/326369.
33. You H, Liu Y, Agrawal N, Prasad CK, Edwards JL,
Osborne AF, Korourian S, Lowery CL, Hermonat PL.
Multiple human papillomavirus types replicate in 3A
trophoblasts. Placenta. 2008;29:30–38. doi:10.1016/j.
placenta.2007.08.005.
34. Walker CK, Anderson KW, Milano KM, Ye S, Tan-
credi DJ, Pessah IN, Hertz-Picciotto I, Kliman HJ.
Trophoblast inclusions are signiﬁcantly increased in
the placentas of children in families at risk for autism.
Biol Psychiatry. 2013;74(3):204–211. doi:10.1016/j.
biopsych.2013.03.006.
35. https://www.rcog.org.uk/globalassets/documents/guide
lines/gtg_27.pdf Accessed on 01/11/2017
36. Demissie K, Breckenridge MB, Joseph L, Rhoads GG.
Placenta previa: preponderance of male sex at birth.
Am J Epidemiol. 1999;149:824–830. doi:10.1093/
oxfordjournals.aje.a009898.
37. Wen SW, Demissie K, Liu S, Marcoux S, Kramer MS. Pla-
centa praevia and male sex at birth: results from a popula-
tion-based study. Paediatr Perinat Epidemiol. 2000;14
(4):300–304. doi:10.1046/j.1365-3016.2000.00280.x
38. Ananth CV, Demissie K, Smulian JC, Vintzileos AM.
Placenta previa in singleton and twin births in the
United States, 1989 through 1998: a comparison of
risk factor proﬁles and associated conditions. Am J
e1387702-8 D. E GODAR AND S. J. MERRILL
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
Obstet Gynecol. 2003;188:275–281. doi:10.1067/
mob.2003.10.
39. Greenberg DA, Hodge SE, Sowinski J, Nicoll D.
Excess of twins among affected sibling pairs with
autism: implications for the etiology of autism. Am J
Hum Genet. 2001;69:1062–1067. doi:10.1086/324191.
PMID:11590546
40. Betancur C, Leboyer M, Gillberg C. Increased rate of
twins among affected sibling pairs with autism. Am J
Hum Genet. 2002;70:1381–1383. doi:10.1086/340364.
41. Getahun D, Oyelese Y, Salihu HM, Ananth CV. Previ-
ous cesarean delivery and risks of placenta previa and
placental abruption. Obstet Gynecol. 2006;107(4):771–
778. doi:10.1097/01.AOG.0000206182.63788.80.
PMID:16582111
42. Curran EA, Dalman C, Kearney PM, Kenny LC,
Cryan JF, Dinan TG, Khashan AS. Association
between obstetric mode of delivery and autism spec-
trum disorder: A population-based sibling design
study. JAMA Psychiatry. 2015;72(9):935–942.
doi:10.1001/jamapsychiatry.2015.0846.
43. Ananth CV, Wilcox AJ, Savitz DA, Bowes WA Jr., Luther
ER. Effect of maternal age and parity on the risk of utero-
placental bleeding disorders in pregnancy. Obstet Gyne-
col. 1996;88(4 Pt 1):511–516.
44. Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB,
Parry S. Placental infection with human papillomavirus
is associated with spontaneous preterm delivery. Human
reproduction. 2008;23:709–715. doi:10.1093/humrep/
dem404.
45. Zuo Z, Goel S, Carter JE. Association of cervical
cytology and HPV DNA status during pregnancy with
placental abnormalities and preterm birth. Am J Clin
Pathol. 2011;136:260–265. doi:10.1309/AJCP93JMIUE
KRPIW.
46. Wolburg H, Paulus W. Choroid plexus: biology and
pathology. Acta Neuropathol. 2010;119(1):75–88.
doi:10.1007/s00401-009-0627-8.
47. Liddelow SA. Development of the choroid plexus and
blood-CSF barrier. Front Neurosci. 2015;9: 32.
doi:10.3389/fnins.2015.00032. PMID:25784848
48. Minshew NJ, Williams DL. The new neurobiology of
autism. Cortex, connectivity, and neuronal organiza-
tion. Arch Neurol. 2007;64:945–950. doi:10.1001/
archneur.64.7.945.
49. Praetorius J, Nejsum LN, Nielsen S. A SCL4A10 gene
product maps selectively to the basolateral plasma
membrane of choroid plexus epithelial cells. Am J
Physiol Cell Physiol. 2004;286(3):C601¡610.
doi:10.1152/ajpcell.00240.2003.
50. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C,
Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, et al.
Strong association of de novo copy number mutations
with autism. Science. 2007;316(5823):445–449.
doi:10.1126/science.1138659.
51. Sinning A, Liebmann L, H€ubner CA. Disruption of
Slc4a10 augments neuronal excitability and modulates
synaptic short-term plasticity. Front Cell Neurosci.
2015;9:223. doi:10.3389/fncel.2015.00223. PMID:26136660
52. Gurnett CA, Veile R, Zempel J, Blackburn L, Lovett M,
Bowcock A. Disruption of sodium bicarbonate trans-
porter SLC4A10 in a patient with complex partial epi-
lepsy and mental retardation. Arch Neurol. 2008;65
(4):550–552. doi:10.1001/archneur.65.4.550.
53. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino
PB. Detection of human papillomavirus in human focal
cortical dysplasia type IIB. Ann Neurol. 2012;72:881–
892. doi:10.1002/ana.23795.
54. Casanova MF, El-Baz AS, Kamat SS, Dombroski BA,
Khalifa F, Elnakib A, Soliman A, Allison-McNutt A, Swi-
tala AE. Focal cortical dysplasias in autism spectrum dis-
orders. Acta Neuropathol Commun. 2013;1:67.
doi:10.1186/2051-5960-1-67. PMID:24252498
55. Abdulkader MM, Mansour NH, Van Gompel JJ, Bosh
GA, Dropcho EJ, Bonnin JM, Cohen-Gadol AA. Dissem-
inated choroid plexus papillomas in adults: A case series
and review of the literature. J Clin Neurosci.
2016;32:148–154. doi:10.1016/j.jocn.2016.04.002.
56. Prasad GL, Mahapatra AK. Case series of choroid plexus
papilloma in children at uncommon locations and review
of the literature. Surg Neurol Int. 2015;6:151. doi:10.4103/
2152-7806.166167. PMID:26500797
57. Ogiwara H, Dipatri AJ Jr., Alden TD, Bowman RM,
Tomita T.Choroid plexus tumors in pediatric patients.
Br J Neurosurg. 2012;26(1):32–37. doi:10.3109/
02688697.2011.601820.
58. Horvath K, Perman JA. Autistic disorder and gastrointes-
tinal disease. Curr Opin Pediatr. 2002;14(5):583–587.
doi:10.1097/00008480-200210000-00004.
59. de Jonge WJ. The Gut’s Little Brain in Control of Intesti-
nal Immunity. ISRN Gastroenterol. 2013;2013:630159.
doi:10.1155/2013/630159. PMID:23691339
60. Vargas DL, Nascimbene C, Krishnan C, Zimmerman
AW, Pardo CA. Neuroglial activation and neuroinﬂam-
mation in the brain of patients with autism. Ann Neurol.
2005;57(1):67–81. Erratum in: Ann Neurol. 2005;57
(2):304. doi:10.1002/ana.20315.
61. Shastri A, Bonifati DM, Kishore U. Innate immunity
and neuroinﬂammation. Mediators Inﬂamm. 2013
(2013):342931. doi:10.1155/2013/342931. [Epub 2013
Jun 15]. Review. PMID:23843682
62. Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J,
West AB, Arking DE. Transcriptome analysis reveals
dysregulation of innate immune response genes and neu-
ronal activity-dependent genes in autism. Nat Commun.
2014;5:5748–5755. doi:10.1038/ncomms6748.
63. Cannell JJ, Grant WB, Holick MF. Vitamin D and
inﬂammation. Dermato-Endocrinol. 2015;6(1):e983401.
doi:10.4161/19381980.2014.983401.
64. Shen MD, Kim SH, McKinstry RC, Gu H, Hazlett HC,
Nordahl CW, Emerson RW, Shaw D, Elison JT, Swanson
MR, Fonov VS, Gerig G, Dager SR, Botteron KN, Pater-
son S, Schultz RT, Evans AC, Estes AM, Zwaigenbaum L,
Styner MA, Amaral DG, Piven J; Infant Brain Imaging
DERMATO-ENDOCRINOLOGY e1387702-9
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
Study Network; Infant Brain Imaging Study Network,
The Infant Brain Imaging Study (IBIS) Network is a
National Institutes of Health–funded Autism Center of
Excellence project and consists of a consortium of eight
universities in the United States and Canada, Piven J,
Hazlett HC, Chappell C, Dager S, Estes A, Shaw D, Bot-
teron K, McKinstry R, Constantino J, Pruett J, Schultz R,
Zwaigenbaum L, Elison J, Evans AC, Collins DL, Pike
GB, Fonov V, Kostopoulos P, Das S, Gerig G, Styner M,
Gu H. Increased extra-axial cerebrospinal ﬂuid
in high-risk infants who later develop autism.
Biological Psychiatry 2017;82(3):186–193. doi:10.1016/j.
biopsych.2017.02.1095. [Epub 2017 Mar 6]. PMID:
28392081
65. Crawley JN, Heyer WD, LaSalle JM. Autism and can-
cer share risk genes, pathways, and drug targets.
Trends Genet. 2016;32(3):139–146. doi:10.1016/j.
tig.2016.01.001.
66. Spangle JM, Munger K. The human papillomavirus type
16 E6 oncoprotein activates mTORC1 signaling and
increases protein synthesis. J Virol. 2010;84:9398–9407.
doi:10.1128/JVI.00974-10.
67. Tilot AK, Frazier TW, Eng C. Balancing proliferation and
connectivity in PTEN-associated autism spectrum disor-
der. Neurotherapeutics. 2015;12(3):609–619. doi:10.1007/
s13311-015-0356-8.
68. Lee DY. Roles of mTOR signaling in brain development.
Exp Neurobiol. 2015;24(3):177–185. doi:10.5607/
en.2015.24.3.177.
69. Yi JJ, Berrios J, Newbern JM, Snider WD, Philpot BD,
Hahn KM, Zylka MJ. An autism-linked mutation dis-
ables phosphorylation control of UBE3A. Cell. 2015;162
(4):795–807. doi:10.1016/j.cell.2015.06.045.
70. Brimer N, Lyons C, Vande Pol SB. Association of E6AP
(UBE3A) with human papillomavirus type 11 E6 pro-
tein. Virology. 2007;358(2):303–310. doi:10.1016/j.
virol.2006.08.038.
71. Crespi B. Autism and cancer risk. Autism Res. 2011;4
(4):302–310. doi:10.1002/aur.208.
72. e>Chiang HL, Liu CJ, Hu YW, Chen SC, Hu LY, Shen
CC, Yeh CM, Chen TJ, Gau SS. Risk of cancer in chil-
dren, adolescents, and young adults with autistic disor-
der. J Pediatr. 2015;166(2):418–423. doi:10.1016/j.
jpeds.2014.10.029.
73. Rosenblatt A, de Campos Guidi HG. Human Papilloma-
virus: A Practical Guide for Urologists. Berlin: Springer-
Verlag; 2009.
74. Satterwhite CL, Torrone E, Meites E, Dunne EF,
Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H.
Sexually transmitted infections among US women and
Men: Prevalence and incidence estimated, 2008. Sex.
Trans. Dis. 2013;40:187–193. doi:10.1097/OLQ.
0b013e318286bb53.
75. Vidone M, Alessandrini F, Marucci G, Farnedi A, de
Biase D, Ricceri F, Calabrese C, Kurelac I, Porcelli
AM, Cricca M, et al. Evidence of association of
human papillomavirus with prognosis worsening in
glioblastoma multiforme. Neuro Oncol. 2014;16:298–
302. doi:10.1093/neuonc/not140.
76. F€ule T, Mathe M, Suba Z, Csapo Z, Szarvas T, Tatrai P,
Paku S, Kovalszky I. The presence of human papillo-
mavirus 16 in neural structures and vascular endothe-
lial cells. Virology. 2006;348(2):289–96. doi:10.1016/j.
virol.2005.12.043.
77. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez
BY, Xiao W, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, Liu L, et al. Human papillomavirus and ris-
ing oropharyngeal cancer incidence in the United
States. J Clin Oncol. 2011;29:4294–4301. doi:10.1200/
JCO.2011.36.4596.
78. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Mel-
ton LJ 3, Wermers RA. Secular trends in the inci-
dence of primary hyperparathyroidism over ﬁve
decades (1965–2010). Bone. 2015;73:1–7. doi:10.1016/
j.bone.2014.12.003.
79. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and
immune function. Nutrients. 2013;5(7):2502–2521.
doi:10.3390/nu5072502.
80. Beard JA, Bearden A, Striker R. Vitamin D and the anti-
viral state. J Clin Virol. 2011;50(3):194–200. doi:10.1016/
j.jcv.2010.12.006.
81. Kasiappan R, Sun Y, Lungchukiet P, Quarni W, Zhang X,
Bai W. Vitamin D suppresses leptin stimulation of cancer
growth through microRNA. Cancer Res. 2014;74
(21):6194–6204.doi:10.1158/0008-5472.CAN-14-1702.
82. Ashwood P, Kwong C, Hansen R, Hertz-Picciotto I,
Croen L, Krakowiak P, Walker W, Pessah IN, Van de
Water J. Brief report: plasma leptin levels are elevated in
autism: association with early onset phenotype? J Autism
Dev Disord. 2008;38(1):169–175. doi:10.1007/s10803-
006-0353-1.
83. Baker R, Dauner JG, Rodriguez AC, Williams MC, Kemp
TJ, Hildesheim A, Pinto LA. Increased plasma levels of
adipokines and inﬂammatory markers in older women
with persistent HPV infection. Cytokine. 2011;52
(3):282–285. doi:10.1016/j.cyto.2010.11.014
84. McDonnold M, Dunn H, Hester A, Pacheco LD, Hankins
GD, Saade GR, Costantine MM. High risk human papil-
lomavirus at entry to prenatal care and risk of preeclamp-
sia. Am J Obstet Gynecol. 2014;210(2):138.e1¡5.
doi:10.1016/j.ajog.2013.09.040.
85. Walker CK, Krakowiak P, Baker A, Hansen RL, Ozonoff
S, Hertz-Picciotto I. Preeclampsia, placental insufﬁciency,
and autism spectrum disorder or developmental delay.
JAMA Pediatr. 2015;169(2):154–162. doi:10.1001/
jamapediatrics.2014.2645.
86. Goldstein JM, Seidman LJ, Horton NJ, Makris N,
Kennedy DN, Caviness VS Jr., Faraone SV, Tsuang
MT. Normal sexual dimorphism of the adult human
brain assessed by in vivo magnetic resonance imaging.
Cereb Cortex. 2001;11:490–497. doi:10.1093/cercor/
11.6.490.
87. Gingelmaier A, Gutsche S, Mylonas I, Shabani N, Kuhn
C, Kunze S, Jeschke U, Friese K. Expression of HPV,
e1387702-10 D. E GODAR AND S. J. MERRILL
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and
inhibin/activin subunits (alpha, betaA and betaB) in
adenosquamous endometrial carcinoma. Anticancer Res.
2007;27:2011–2017. http://ar.iiarjournals.org/content/27/
4A/2011.long
88. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
Regulation of vitamin D receptor expression via estro-
gen-induced activation of the ERK 1/2 signaling pathway
in colon and breast cancer cells. J Endocrinol.
2005;185:577–592. doi:10.1677/joe.1.05770.
89. Gallego MI, Lazo PA. Deletion in human chromosome
region 12q13-15 by integration of human papillomavirus
DNA in a cervical carcinoma cell line. JBC.
1995;270:24321–24326. doi:10.1074/jbc.270.41.24321.
90. Taymans SE, Pack S, Pak E, Orban Z, Barsony J, Zhuang
Z, Stratakis CA. The human vitamin D receptor gene
(VDR) is localized to region 12cen-ql2 by ﬂuorescent in
situ hybridization and radiation hybrid mapping: genetic
and physical VDR map. J Bone Miner Res. 1999;14:
1163–1166. doi:10.1359/jbmr.1999.14.7.1163.
91. Schabath MB, Villa LL, Lin HY, Fulp WJ, Akoqbe GO,
Abrahamsen ME, Papenfuss MR, Lazcano-Ponce E,
Salmeron J, Quiterio M, et al. Racial differences in the
incidence and clearance of human papilloma virus
(HPV): the HPV in men (HIM) study. Cancer Epidemiol
Biomarkers Prev. 2013;22(10):1762–1770. doi:10.1158/
1055-9965.EPI-13-0303.
92. Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de
Water J, Pessah IN. The CHARGE study: an epidemio-
logic investigation of genetic and environmental factors
contributing to autism. Environ Health Perspect.
2006;114(7):1119–1125. doi:10.1289/ehp.8483.
93. Poletaev AB, Shenderov BA. Autism: Genetics or Epi-
genetics? ARC J Immunol Vaccines. 2016;1(2):1–7.
https://www.arcjournals.org/pdfs/ajiv/v1-i2/1.pdf
94. Robinson JL, Nations L, Suslowitz N, Cuccaro ML,
Haines J, Pericak-Vance M. Prevalence rates of autism
spectrum disorders among the Old Order Amish,
Abstract for International Meeting for Autism Research
2010 Paper 7336. https://imfar.confex.com/imfar/2010/
webprogram/Paper7336.html
95. Yin J, Schaaf CP. Autism genetics – an overview. Prenat
Diagn. 2017;37(1):14–30. doi:10.1002/pd.4942.
96. Laplana M, Royo JL, Aluja A, Lopez R, Heine-Sunyer D,
Fibla J. Absence of substantial copy number differences in a
pair of monozygotic twins discordant for features of autism
spectrum disorder. Case Rep Genet. 2014;2014:516529.
doi:10.1155/2014/516529. PMID:24563798
97. Bourgeron T. From the genetic architecture to synaptic
plasticity in autism spectrum disorder. Nat Rev Neurosci.
2015;16(9):551–563. doi:10.1038/nrn3992.
98. Loke YJ, Hannan AJ, Craig JM. The Role of Epige-
netic Change in Autism Spectrum Disorders. Front
Neurol. 2015;6:107. doi:10.3389/fneur.2015.00107.
PMID:26074864
99. Ziats MN, Rennert OM. The Evolving Diagnostic and
Genetic Landscapes of Autism Spectrum Disorder. Front
Genet. 2016;7:65. doi:10.3389/fgene.2016.00065.
PMID:27200076
100. Wu YE, Parikshak NN, Belgard TG, Geschwind DH.
Genome-wide, integrative analysis implicates micro-
RNA dysregulation in autism spectrum disorder.
Nat Neurosci. 2016;19(11):1463–1476. doi:10.1038/
nn.4373.
101. Miranda PM, Silva NN, Pitol BC, et al. Persistence
or clearance of human papillomavirus infections in
women in Ouro Preto, Brazil. Biomed Res Int.
2013;2013:578276. doi:10.1155/2013/578276.
PMID:24298551
102. Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR,
Schalkwyk LC, Plomin R, Mill J. Methylomic analysis of
identical twins discordant for autism spectrum disorder
and related behavioural traits. Mol Psychiatry. 2014;19
(4):495–503. doi:10.1038/mp.2013.41.
103. Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A,
Brown KD. Quantitative DNA methylation analysis of
candidate genes in cervical cancer. PLoS One. 2015;10
(3):e0122495. doi:10.1371/journal.pone.0122495.
PMID:25826459
104. Anayannis NV, Schlecht NF, Belbin TJ. Epigenetic mech-
anisms of human papillomavirus-associated head and
neck cancer. Arch Pathol Lab Med. 2015;139(11):1373–
1378. doi:10.5858/arpa.2014-0554-RA.
105. Wentzensen N, Ridder R, Klaes R, Vinokurova S,
Schaefer U, Doeberitz MK. Characterization of viral-cel-
lular fusion transcripts in a large series of HPV16 and 18
positive anogenital lesions. Oncogene. 2002;21: 419–426.
doi:10.1038/sj.onc.1205104.
106. Wentzensen N, Vinokurova S, von Knebel Doeberitz M.
Systematic review of genomic integration sites of human
papillomavirus genomes in epithelial dysplasia and inva-
sive cancer of the female lower genital tract. Cancer Res.
2004;64(11):3878–3884. doi:10.1158/0008-5472.CAN-04-
0009.
107. Schmitz M, Driesch C, Jansen L, Runnebaum IB, D€urst
M. Non-random integration of the HPV genome in cer-
vical cancer. PLoS One. 2012;7(6): e39632. doi:10.1371/
journal.pone.0039632. PMID:22761851
108. Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W,
Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D,
et al. Genome-wide analysis of HPV integration in
human cancers reveals recurrent, focal genomic instabil-
ity. Genome Res. 2014;24(2):185–199. doi:10.1101/
gr.164806.113.
109. Smith CL, Bolton A, Nguyen G. Genomic and epigenomic
instability, fragile sites, schizophrenia and autism. Curr
Genomics. 2010b;11(6):447–469. doi:10.2174/
138920210793176001.
110. Cooper DN, Mort M, Stenson PD, Ball EV, Chuzhanova
NA. Methylation- mediated deamination of 5-methylcy-
tosine appears to give rise to mutations causing human
inherited disease in CpNpG trinucleotides, as well as in
CpG dinucleotides. Hum Genomics. 2010;4(6):406–410.
doi:10.1186/1479-7364-4-6-406.
DERMATO-ENDOCRINOLOGY e1387702-11
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
111. Kaspersen MD, Larsen PB, Ingerslev HJ, Fedder J,
Petersen GB, Bonde J, H€ollsberg P. Identiﬁcation of multi-
ple HPV types on spermatozoa from human sperm
donors. PLoS One. 2011;6(3):e18095. doi:10.1371/journal.
pone.0018095. PMID:21479232
112. Lee SM, Park JS, Norwitz ER, Koo JN, Oh IH, Park
JW, Kim SM, Kim YH, Park CW, Song YS. Risk of
vertical transmission of human papillomavirus
throughout pregnancy: a prospective study. PLoS
One. 2013;8(6):e66368. doi:10.1371/journal.
pone.0066368. PMID:23785495
113. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun
MS, Kim SH, Jeong JK. Correlation of cervical carcinoma
and precancerous lesions with human papillomavirus
(HPV) genotypes detected with the HPV DNA chip
microarray method. Cancer. 2003;97(7):1672–1680.
doi:10.1002/cncr.11235. PMID:12655524
114. Dzuba IG, Dıaz EY, Allen B, Leonard YF, Lazcano
Ponce EC, Shah KV, Bishai D, Lorincz A, Ferris D,
Turnbull B, et al. The acceptability of self-collected
samples for HPV testing vs. the Pap test as alterna-
tives in cervical cancer screening. Journal of Women’s
Health & Gender-Based Medicine. 2002;11:265–274.
doi:10.1089/152460902753668466.
115. Venuti A, Paolini F. HPV detection methods in head and
neck cancer. Head Neck Pathol. 2012;6 Suppl 1:S63¡74.
doi:10.1007/s12105-012-0372-5
116. Abreu AL, Souza RP, Gimenes F, Consolaro ME. A
review of methods for detect human papillomavirus
infection. Virol J. 2012;9:262. doi:10.1186/1743-422X-9-
262. PMID:23131123
117. Coras R, Korn K, Bien CG, Kalbhenn T, R€ossler K,
Kobow K, Giedl J, Fleckenstein B, Blumcke I. No evi-
dence for human papillomavirus infection in focal corti-
cal dysplasia IIb. Ann Neurol. 2015;77(2):312–319.
doi:10.1002/ana.24328.
118. den Boon JA, Pyeon D, Wang SS, Horswill M, Schiff-
man M, Sherman M, Sherman M, Zuna RE, Wang Z,
Hewitt SM, et al. Molecular transitions from papillo-
mavirus infection to cervical precancer and cancer:
Role of stromal estrogen receptor signaling. Proc Natl
Acad Sci USA. 2015;112(25):E3255–3264. doi:10.1073/
pnas.1509322112.
119. Heaney RP, Garland C, Baggerly C, French C, Gorham E.
Letter to Veugelers, P.J. and Ekwaru, J.P., A statistical
error in the estimation of the recommended dietary
allowance for vitamin D. Nutrients. 2015;7:1688–1690.
doi:10.3390/nu7031688
120. Holick MF: The vitamin D deﬁciency pandemic:
Approaches for diagnosis, treatment and prevention. Rev
Endocr Metab Disord. 2017 18(2):153–165. Review.
doi:10.1007/s11154-017-9424-1.
121. Kimball SM, Mirhosseini N, Holick MF. Evaluation
of vitamin D3 intakes up to 15,000 international
units/day and serum 25-hydroxyvitamin D concen-
trations up to 300 nmol/L on calcium metabolism in
a community setting. Dermatoendocrinol. 2017 9(1):
e1300213. eCollection 2017. doi:10.1080/19381980.
2017.1300213. PMID:28458767
122. Holick MF. Vitamin D and brain health: the need for
vitamin D supplementation and sensible sun exposure. J
Intern Med. 2015 277(1):90–93. Epub 2014 Nov 13.
doi:10.1111/joim.12308.
123. Crino PB. The mTOR signalling cascade: paving new
roads to cure neurological disease. Nat Rev Neurol. 2016
12(7):379–392. doi:10.1038/nrneurol.2016.81.
124. Sato A. mTOR, a potential target to treat autism spectrum
disorder. CNS Neurol Disord Drug Targets. 2016;15(5):523–
543. doi:10.2174/1871527315666160413120638.
125. Coppock JD, Wieking BG, Molinolo AA, Gutkind JS, Mis-
kimins KW, Lee JH. Improved clearance during treatment
of HPV-positive head and neck cancer through mTOR
inhibition. Neoplasia. 2013;15(6):620–630. doi:10.1593/
neo.13432.
126. Scheller NM, Pasternark B, Molgaard-Nielsen D,
Svanstr€om H, Hviid A. Quadrivalent HPV Vaccination
and the Risk of Adverse Pregnancy Outcomes. N Engl J
Med. 2017;376:1223–1233. doi:10.1056/NEJMoa1612296.
127. Cyrus N, Blechman AB, Leboeuf M, Belyaeva EA, de
Koning MN, Quint KD, Stern JJ. Effect of quadrivalent
human papillomavirus vaccination on oral squamous cell
papillomas. JAMA Dermatol. 2015;151(12):1359–1363.
doi:10.1001/jamadermatol.2015.2805.
128. Ali H, Donovan B, Wand H, Read TR, Regan DG,
Grulich AE, Fairley CK, Guy RJ. Genital warts in young
Australians ﬁve years into national human papillomavi-
rus vaccination programme: national surveillance data.
BMJ. 2013;346:f2032. Erratum in: BMJ. 2013;346:F2942.
doi:10.1136/bmj.f2032. PMID:23599298
129. Godar DE, Subramanian M, Merrill SJ. Cutaneous malig-
nant melanoma incidences analyzed worldwide by sex,
age, and skin type over personal Ultraviolet-B dose shows
no role for sunburn but implies one for vitamin D3. Der-
matoendocrinol. 2016;9(1):e1267077. doi:10.1080/
19381980.2016.1267077. eCollection 2017. PMID:
28924456
130. Merrill SJ, Subramanian M, Godar DE. Worldwide cuta-
neous malignant melanoma incidences analyzed by sex,
age, and skin type over time (1955–2007): Is HPV
infection of androgenic hair follicular melanocytes a risk
factor for developing melanoma exclusively in people
of European-ancestry? Dermatoendocrinol. 2016;8(1):
e1215391. doi:10.1080/19381980.2016.1215391.
PMID:27588159
131. Godar DE, Subramanian M, Merrill SJ. Cutaneous malig-
nant melanoma incidences analyzed worldwide by skin
type over advancing age of males and females: Evidence
estrogen and androgenic hair are risk factors. J Epi Res.
2017;3(10): doi:10.5430/jer.v3n1p42
132. Boontanrart M, Hall SD, Spanier JA, Hayes CE, Olson JK.
Vitamin D3 alters microglia immune activation by an IL-
10 dependent SOCS3 mechanism. J Neuroimmunol.
2016;292:126–36. Epub 2016 Jan 27. doi:10.1016/j.
jneuroim.2016.01.015.
e1387702-12 D. E GODAR AND S. J. MERRILL
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
133. Godar DE, Gurov R, Merrill SJ. All Sites but Skin Cancer
Incidences Analyzed Worldwide by Sex, Age, and Skin
Type over Time (1955–2007), Advancing Age, and UVB
Dose Reveals Important Carcinogenic Drivers. J Epi Res.
2017;3(2):65–80.
134. Hossein-nezhadA, Spira A, HolickMF. Inﬂuence of vitamin
D status and vitamin D3 supplementation on genome wide
expression of white blood cells: a randomized double-blind
clinical trial. PLoS One. 2013;8(3):e58725. Epub 2013 Mar
20. doi:10.1371/journal.pone.0058725. PMID:23527013
DERMATO-ENDOCRINOLOGY e1387702-13
D
ow
nl
oa
de
d 
by
 [M
arq
ue
tte
 U
niv
ers
ity
] a
t 0
7:4
0 0
8 N
ov
em
be
r 2
01
7 
